|Articles|November 7, 2022
Calyx Enhances IRT System
Intelligent functionality removes supply team burdens while ensuring drug availability and reducing waste.
Advertisement
Calyx announced an enhancement to its interactive response technology (IRT) system. By removing the supply monitoring burden from clinical trial teams, Calyx IRT's automated supply strategy management reduces the cost of drug waste while ensuring the study drug is available at investigative sites on time.
Read more about the enhancement
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
Breaking Out of AI Pilot Mode in Clinical Development
3
ACT Brief: Community Sites Compete on Readiness, COA Licensing Bottlenecks Slow Start-Up, and AI’s Foundations in Pharmacovigilance
4
ACT Brief: Community Sites Prove Readiness, Platformization Reshapes Clinical Ops, and AI Targets Precision Care at JPM
5